ライフサイエンスコーパス: school-aged

1 d for 6 wk, is an effective intervention for school-aged (5-10 y old) children with FASDs.

2 in childhood (aged 0-5 years) or elementary school (aged 6-12 years) O(3) exposure was associated wi

3 t, notably physical activity, need to target school-aged and possibly younger children.

4 atric population including neonate, toddler, school-aged, and adolescents.

5 aggression was tested in 38 clinic-referred school-aged boys.

6 wth standards" and "WHO growth standards for school aged children and adolescents" for children up to

7 The epidemiology of this condition in school aged children is poorly understood.

8 [0.5%] exposed to farm animals) and 276,298 school-aged children (22,629 [8.2%] exposed to dogs and

9 the highest prevalence of schistosomiasis in school-aged children (52.8%, 95% CrI 48.7-57.8).

10 Participants were medication naive school-aged children (ages 7-11) with PO-MDD (n = 22) or

11 st effective compared with treatment of only school-aged children (ICER $167 per DALY averted) and WH

12 Most of the patients were school-aged children (mean [+/-SD] age, 7.8+/-3.5 years;

13 ssociated with a decreased risk of asthma in school-aged children (OR, 0.87; 95% CI, 0.81-0.93) and i

14 he neuropsychological functioning of healthy school-aged children after an overnight fast.

15 Vaccinating school-aged children against influenza can reduce age-sp

16 reatment costs were estimated at US$0.74 for school-aged children and $1.74 for preschool-aged childr

17 In the United States, 4 of 10 school-aged children and 1 of 3 adolescents are involunt

18 ion (95% CrI 121 million to 125 million) for school-aged children and 247 million (239 million to 256

19 sentially uncharted, and existing studies in school-aged children and adolescents are confounded grea

20 RS was reasonably common in this cohort of school-aged children and adolescents in Sri Lanka.

21 school children, 30% predominantly affecting school-aged children and adolescents, and 6% with no pre

22 ort covers disorders diagnosed more often in school-aged children and adolescents.

23 This recommendation applies to school-aged children and adolescents.

24 ing, to prevent initiation of tobacco use in school-aged children and adolescents.

25 left hemispheric posterior brain regions for school-aged children and adults with a diagnosis of DD.

26 rs of reading skills have been identified in school-aged children and adults; many pertain to the pre

27 rrent diagnosis of asthma at age 6 years for school-aged children and as the hazard ratio (HR) for in

28 ic memory B cells at steady state in primary school-aged children and little association with MenC Ig

29 ciated with a reduced risk of asthma in both school-aged children and preschool-aged children (OR, 0.

30 h 75% coverage in only school-aged children; school-aged children and preschool-aged children; adults

31 life circumstances of a community sample of school-aged children and then followed these children fo

32 y rate relative to baseline were greatest in school-aged children and young adults, with no evidence

33 se has come from population-based studies of school-aged children and young adults.

34 of Austria, Germany, and Switzerland, 79,888 school-aged children answered a recruiting questionnaire

35 Eighty-nine percent of school-aged children are in school full-time, 18 months

36 is was highly cost-effective in treatment of school-aged children at a prevalence of 20% (95% UI 5.4-

37 is was highly cost-effective in treatment of school-aged children at a prevalence threshold of 5% (95

38 e helpful in providing the time to vaccinate school-aged children before the pandemic peaks.

39 worm control has been morbidity reduction in school-aged children by periodic deworming with benzimid

40 Improving the health of school-aged children can yield substantial benefits for

41 or socioeconomic status (Health Behaviour in School-aged Children Family Affluence Scale) and health

42 Weekly volunteering with elementary school-aged children for 2 months vs wait-list control g

43 kworm, A lumbricoides, and T trichiura among school-aged children from 2000 onwards was 16.5%, 6.6%,

44 ross-sectional survey was carried out on 693 school-aged children from 5 schistosomiasis-endemic vill

45 cted from 4512 ethnically diverse, nonmyopic school-aged children from grades 1 through 8 (baseline g

46 research summer camp program for low-income, school-aged children from July 1, 1986, to August 15, 20

47 For unknown reasons, school-aged children have substantially higher infection

48 at shorter intervals were compared in middle-school-aged children immunized with two doses separated

49 ysis sheds quantitative light on the role of school-aged children in measles cross-scale dynamics, as

50 l exposure samples (n = 249) of 62 asthmatic school-aged children in Montreal were collected over 10

51 isual functioning of spectacle provision for school-aged children in Oaxaca, Mexico.

52 ssure measurements and myopia progression in school-aged children in Taiwan.

53 The prevalence of asthma in school-aged children in the target area is 19-25%, which

54 The stable overall suicide rate in school-aged children in the United States during 20 year

55 By fall of 2001, most (82%) school-aged children in the United States were in grades

56 gh vaccination coverage among preschool- and school-aged children in the United States.

57 ctive error and visual impairment in primary school-aged children in this region.

58 Recommendations for school-aged children include 60 minutes of daily moderat

59 and targeting 2 potential high-risk groups: school-aged children initiating stimulant medications to

60 h preventive chemotherapy usually focused on school-aged children instead.

61 transmitted helminthiasis when prevalence in school-aged children is at or above a threshold of 50% a

62 Low-risk countries (prevalence among school-aged children lower than 10%) included Burundi, E

63 School-aged children may play an important role in pertu

64 he basis of WHO guidelines (treatment of all school-aged children once per year where prevalence in t

65 For households with school-aged children only (no children 0-5 years), IC ha

66 in early life and persistent wheeze (PW) in school-aged children remains uncertain.

67 thma and wheezing were investigated in 5,762 school-aged children residing in 12 Southern California

68 tion of 2 doses of varicella vaccine for all school-aged children should be incorporated into the sta

69 Second to their home, school-aged children spend the largest portion of their

70 nalysis of data from the Health Behaviour in School-aged Children study, in which cross-sectional sur

71 is associated with allergic sensitization in school-aged children suggesting systemic low-grade infla

72 ld Health Organization's Health Behaviour in School-aged Children survey during the spring of 1998.

73 rtance of regular screening of preschool and school-aged children to reduce the development and progr

74 The rate of appendiceal rupture in school-aged children was associated with race and health

75 tinuum in a large population-based sample of school-aged children were found.

76 Fifty-six percent of school-aged children were receiving additional support a

77 cRCT in closely connected communities where school-aged children were vaccinated: 60% (95% confidenc

78 ainst tuberculosis from BCG revaccination in school-aged children who had had one BCG vaccination as

79 e, an immunization campaign that targets all school-aged children who lack two doses may be an effect

80 to improved adherence and asthma outcomes in school-aged children who presented to the emergency depa

81 The cognitive and behavioral outcomes of school-aged children who were born preterm have been rep

82 School-aged children with a history of PO-MDD showed pat

83 s in adherence to inhaled corticosteroids in school-aged children with asthma.

84 a killed Mycobacterium vaccae suspension to school-aged children with atopic dermatitis ameliorates

85 Ocular signs appear in roughly half of school-aged children with Fabry disease and are well-rec

86 Vaccinating school-aged children with LAIV is likely to be cost-effe

87 tion concentrated on a small area, including school-aged children with low background incidence of ca

88 Suicide is a leading cause of death among school-aged children younger than 12 years but little is

89 In the school-aged children's cohort, 11,585 children (4.2%) ex

90 est that food insecurity was associated with school-aged children's emotional problems but not with t

91 Among school-aged children, 0.1% were classified as stunted an

92 t included 17,696 children aged <5 y, 25,508 school-aged children, 28,328 adolescents, 89,164 adults,

93 udies were, however, performed in adults and school-aged children, and only a little is known about h

94 ion Deficit Hyperactivity Disorder (ADHD) in school-aged children, and there is an increasing trend t

95 and individual levels in children <5 y old, school-aged children, and women of reproductive age.

96 ion of A(H1N1)pdm09 infections included more school-aged children, compared with seasonal influenza A

97 iciency was found in 2.8%, 0.7%, and 8.4% of school-aged children, respectively.

98 erd immunity' associated with immunizing all school-aged children, the suboptimal antigenic match bet

99 Although the highest infection risk was in school-aged children, there were important heterogeneiti

100 classification rules for identifying CRS in school-aged children, using laboratory biomarkers.

101 parasitic infections emphasise treatment of school-aged children, using separate treatment guideline

102 Notably, AC school-aged children, who comprise 5% of the population

103 ers, counterintuitively, perform better than school-aged children, who in turn perform better than ad

104 (Feno), and risks of wheezing and asthma in school-aged children.

105 a major cause of asthma exacerbations among school-aged children.

106 ssociated with physician-diagnosed asthma in school-aged children.

107 with A(H1N1)pdm09, including around half of school-aged children.

108 nfection was 15.5% overall and highest among school-aged children.

109 (OR, 2.09; 95% BCI, 1.35-3.16) but not among school-aged children.

110 iated with lower hemoglobin level only among school-aged children.

111 on, and cost associated with vaccinating all school-aged children.

112 nt cause of acute exacerbations of asthma in school-aged children.

113 ric femoral shaft fractures, particularly in school-aged children.

114 isk or severity of respiratory infections in school-aged children.

115 carried out in stages, focusing initially on school-aged children.

116 e 90.2% for preschool children and 99.8% for school-aged children.

117 on neuropsychological functioning in healthy school-aged children.

118 to use of acellular pertussis vaccines among school-aged children.

119 inated children aged <2 years and vaccinated school-aged children.

120 invasive streptococcal clone among community school-aged children.

121 ore throat, and throat swabs of asymptomatic school-aged children.

122 f regulatory molecules was undertaken in 121 school-aged children.

123 sitemia was high across all ages, peaking in school-aged children.

124 adults were ten times greater than those for school-aged children.

125 cy and diagnosis of a learning disability in school-aged children.

126 athematics and science courses to their high-school-aged children.

127 pregnancy with kidney volume and function in school-aged children.

128 ociated with asthma phenotypes in inner-city school-aged children.

129 al and infant growth with kidney function in school-aged children.

130 aily television exposure among preschool and school-aged children.

131 th subclinical changes in kidney outcomes in school-aged children.

132 ms can efficiently immunize large numbers of school-aged children.

133 reinfection were observed in this sample of school-aged children.

134 (WSH) with administration of praziquantel to school-aged children.

135 ial protection against pH1N1 infection among school-aged children.

136 ensive custom-made spectacles among eligible school-aged children.

137 on between gestational age and 4 outcomes in school-aged children: readiness to enter kindergarten, s

138 reatment programme with 75% coverage in only school-aged children; school-aged children and preschool

139 th adverse neurodevelopmental outcomes among school-aged children; yet, few studies have evaluated pr

140 (H1N1)pdm09 infection were more likely to be school-aged, compared with patients with seasonal influe

141 their household contacts, particularly among school-aged contacts.

142 s isolated from a PEODDN lesion of a primary school-aged female patient with bands of hyperkeratotic-

143 increase maternal HIV-disclosure to primary school-aged HIV-uninfected children.

144 Among school-aged household contacts (aged 5-17 years), there

145 e in five cases aged >18 y was infected by a school-aged household member.

146 School-aged individuals (6-18 y) facilitated the introdu

147 nostic criteria suggest that 3% to 6% of the school-aged population (elementary through high school)

148 not a public health concern in this primary school-aged population; however, visually impaired child

149 The study included 320 school-aged subjects with caregiver-reported IPV in the